In addition, transferrin receptors and LRP-1 are upregulated in dysfunctional the BBB in glioblastoma, and conjugated NPs targeting these receptors have been developed for enhanced drug delivery in glioblastoma cell lines and orthotopic mouse models [148,149]. Here, TFRC is linked to glioblastoma.